Page 36 - Lexaria Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lexaria Provides Progress Report on Six R&D Programs ACCESSWIRE 09 Jun 2021, 21:05 GMT+10 All studies are using DehydraTECH™ 2.0 formulations for multiple market applications, including antivirals, hypertension, NSAIDs and oral nicotine These studies are part of Lexaria's 2021 applied R&D program intended to enable opportunities for strategic partnerships KELOWNA, BC / ACCESSWIRE / June 9, 2021 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (CSE:LXX) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, provides this progress report on several studies within ...

Toronto, Ontario--(Newsfile Corp. - June 2, 2021) - Hill Street Beverage Company Inc. (TSXV: BEER) (the 'Company')  is pleased to announce

First shipment of cannabis infused (V)ia Regal Pink Grape Sparkler sells out in a matter of days Toronto, Ontario--(Newsfile Corp. - June 2, 2021) - Hill Street Beverage Company Inc. (TSXV: BEER) (the

First shipment of cannabis infused ia Regal Pink Grape Sparkler sells out in a matter of daysHill Street Beverage Company Inc.   is pleased to announce that the initial shipment of its first cannabis infused beverage ia RegalTM Pink Grape Sparkler sold-out within a matter of days after launching at the Ontario Cannabis Store and select retailers. A new shipment is expected to be restocked and available in the ...

KELOWNA, BC / ACCESSWIRE / June 3, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that remdesivir